Showing results 17 to 26 of 26
< previous
Issue Date | Title | Author(s) |
2017-02-01 | MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2 | Kim, RY; Horvat, JC; Pinkerton, JW; Starkey, MR; Essilfie, AT; Mayall, JR; Nair, PM; Hansbro, NG; Jones, B; Haw, TJ; Sunkara, KP; Nguyen, TH; Jarnicki, AG; Keely, S; Mattes, J; Adcock, IM; Foster, PS; Hansbro, PM |
2016-01-11 | The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD | Russell, KE; Chung, KF; Clarke, CJ; Durham, AL; Mallia, P; Footitt, J; Johnston, SL; Barnes, PJ; Hall, SR; Simpson, KD; Starkey, MR; Hansbro, PM; Adcock, IM; Wiegman, CH |
2019-06-03 | Molecular links between COPD and lung cancer: new targets for drug discovery? | Caramori, G; Ruggeri, P; Mumby, S; Ieni, A; Lo Bello, F; Chaminka, V; Donovan, C; Andò, F; Nucera, F; Coppolino, I; Tuccari, G; Hansbro, PM; Adcock, IM |
2020-09-29 | New drugs under development for COPD. | Lo Bello, F; Hansbro, PM; Donovan, C; Coppolino, I; Mumby, S; Adcock, IM; Caramori, G |
2021-10-19 | Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. | Pinkerton, JW; Kim, RY; Brown, AC; Rae, BE; Donovan, C; Mayall, JR; Carroll, OR; Khadem Ali, M; Scott, HA; Berthon, BS; Baines, KJ; Starkey, MR; Kermani, NZ; Guo, Y-K; Robertson, AAB; O'Neill, LAJ; Adcock, IM; Cooper, MA; Gibson, PG; Wood, LG; Hansbro, PM; Horvat, JC |
2023 | RNA-binding Proteins as a New Link Between COPD and Lung Cancer | Nucera, F; Salvato, I; Ricciardi, L; Col, JD; Monaco, F; Hansbro, PM; Adcock, IM; Casolaro, V; Stellato, C; Caramori, G |
2020-08-19 | Role of Atypical Chemokines and Chemokine Receptors Pathways In the Pathogenesis of COPD | Nucera, F; Lo Bello, F; Shen, SS; Ruggeri, P; Coppolino, I; Di Stefano, A; Stellato, C; Casolaro, V; Hansbro, PM; Adcock, IM; Caramori, G |
2020-03-19 | Role of the mucins in pathogenesis of COPD: implications for therapy. | Lo Bello, F; Ieni, A; Hansbro, PM; Ruggeri, P; Di Stefano, A; Nucera, F; Coppolino, I; Monaco, F; Tuccari, G; Adcock, IM; Caramori, G |
2023-11-14 | TLR7 promotes smoke-induced experimental lung damage through the activity of mast cell tryptase. | Liu, G; Haw, TJ; Starkey, MR; Philp, AM; Pavlidis, S; Nalkurthi, C; Nair, PM; Gomez, HM; Hanish, I; Hsu, AC; Hortle, E; Pickles, S; Rojas-Quintero, J; Estepar, RSJ; Marshall, JE; Kim, RY; Collison, AM; Mattes, J; Idrees, S; Faiz, A; Hansbro, NG; Fukui, R; Murakami, Y; Cheng, HS; Tan, NS; Chotirmall, SH; Horvat, JC; Foster, PS; Oliver, BG; Polverino, F; Ieni, A; Monaco, F; Caramori, G; Sohal, SS; Bracke, KR; Wark, PA; Adcock, IM; Miyake, K; Sin, DD; Hansbro, PM |
2018-02-01 | Toll-like receptor 2 and 4 have opposing roles in the pathogenesis of cigarette smoke-induced chronic obstructive pulmonary disease | Haw, TJ; Starkey, MR; Pavlidis, S; Fricker, M; Arthurs, AL; Nair, PM; Liu, G; Hanish, I; Kim, RY; Foster, PS; Horvat, JC; Adcock, IM; Hansbro, PM |